Showing 1 - 16 results of 16 for search 'Teng-Yu Lee', query time: 0.06s Refine Results
  1. 1
    Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma

    Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma by Shou-Wu Lee, Li-Shu Chen, Sheng-Shun Yang, Yi-Hsiang Huang, Teng-Yu Lee

    Published 2022-10-01
    Get full text
    Article
  2. 2
    Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation

    Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation by Chia-Yeh Lai, Sheng-Shun Yang, Shou-Wu Lee, Hsin-Ju Tsai, Teng-Yu Lee

    Published 2021-10-01
    Get full text
    Article
  3. 3
    Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study

    Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study by Chia-Yu Lai, Shao-Bin Cheng, Teng-Yu Lee, Yung-Fang Hsiao, Hsiao-Tien Liu, Yi-Chia Huang

    Published 2020-07-01
    Get full text
    Article
  4. 4
    Efficacy of Lenvatinib and Sorafenib in the Real-World First-Line Treatment of Advanced-Stage Hepatocellular Carcinoma in a Taiwanese Population

    Efficacy of Lenvatinib and Sorafenib in the Real-World First-Line Treatment of Advanced-Stage Hepatocellular Carcinoma in a Taiwanese Population by Shou-Wu Lee, Sheng-Shun Yang, Han-Chung Lien, Yen-Chun Peng, Chung-Wang Ko, Teng-Yu Lee

    Published 2022-03-01
    Get full text
    Article
  5. 5
    Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort studyResearch in context

    Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort studyResearch in context by Teng-Yu Lee, Yao-Chun Hsu, Hsiu J. Ho, Jaw-Town Lin, Yi-Ju Chen, Chun-Ying Wu

    Published 2023-07-01
    Get full text
    Article
  6. 6
    The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma

    The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma by Shou-Wu Lee, Sheng-Shun Yang, Han-Chung Lien, Yen-Chun Peng, Chun-Fang Tung, Teng-Yu Lee

    Published 2022-08-01
    Get full text
    Article
  7. 7
    Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.

    Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma. by Chen-Shiou Wu, Teng-Yu Lee, Ruey-Hwang Chou, Chia-Jui Yen, Wei-Chien Huang, Chung-Yi Wu, Yung-Luen Yu

    Published 2014-01-01
    Get full text
    Article
  8. 8
    Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.

    Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma. by Yao-Kuang Huang, Chieh-Ling Yen, Sz-Iuan Shiu, Shou-Wu Lee, Pi-Yi Chang, Hong-Zen Yeh, Teng-Yu Lee

    Published 2017-01-01
    Get full text
    Article
  9. 9
    Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes

    Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes by Yu-Cheng Cheng, Teng-Yu Lee, Yu-Hsuan Li, Chin-Li Lu, Hsiu-Chen Liu, Meei Ling Sheu, I-Te Lee

    Published 2024-02-01
    Get full text
    Article
  10. 10
    Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy

    Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy by Ying-Cheng Lin, Yen-Ju Chen, Shou-Wu Lee, Teng-Yu Lee, Yi-Hsing Chen, Wen-Nan Huang, Sheng-Shun Yang, Yi-Ming Chen

    Published 2021-07-01
    Get full text
    Article
  11. 11
    Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.

    Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma. by Lu-Hung Lee, Jen-I Hwang, Yu-Chi Cheng, Chun-Ying Wu, Shou-Wu Lee, Sheng-Shun Yang, Hong-Zen Yeh, Chi-Sen Chang, Teng-Yu Lee

    Published 2017-01-01
    Get full text
    Article
  12. 12
    Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma

    Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma by Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, Chun-Chieh Yeh, Chao-Ming Tseng, Wen-Hsin Huang, Teng-Yu Lee, Chia-Shen Chu, Jaw-Town Lin

    Published 2022-12-01
    Get full text
    Article
  13. 13
    Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients

    Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients by Yi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen, Chung-Hsin Chang, Szu-Chia Liao, Shou-Wu Lee, Yen-Chun Peng, Teng-Yu Lee, Jun-Sing Wang

    Published 2023-12-01
    Get full text
    Article
  14. 14
    Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment

    Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment by Po-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu, Kun-Chieh Chen, Kuo-Hsuan Hsu, Ho Lin, Teng-Yu Lee, Jeng-Sen Tseng, Gee-Chen Chang, Tsung-Ying Yang

    Published 2022-12-01
    Get full text
    Article
  15. 15
    Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region

    Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region by Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan

    Published 2023-04-01
    Get full text
    Article
  16. 16
    ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation

    ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation by Daniel Q. Huang, Yee Hui Yeo, Eunice Tan, Hirokazu Takahashi, Satoshi Yasuda, Junji Saruwatari, Kenichi Tanaka, Kentaro Oniki, Leslie Y. Kam, Mark D. Muthiah, Hideyuki Hyogo, Masafumi Ono, Scott D. Barnett, Jie Li, Biyao Zou, James Fung, Teng‐Yu Lee, Vincent Wai‐Sun Wong, Man‐Fung Yuen, Yock Young Dan, Seng Gee Lim, Ramsey Cheung, Hidenori Toyoda, Yuichiro Eguchi, Mindie H. Nguyen

    Published 2020-11-01
    Get full text
    Article

Search Tools: